The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
24 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,569,073 in first-year total cost, median $235,295.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-E (56)]17
- Special Emphasis Panel[ZRG1 AARR-P (56)]3
- AIDS Immunology and Pathogenesis Study Section[AIP]1
- AIDS Molecular and Cellular Biology Study Section[AMCB]1
- AIDS-associated Opportunistic Infections and Cancer Study Section[AOIC]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY2
- METHODIST HOSPITAL RESEARCH INSTITUTE2
- UNIVERSITY OF MARYLAND BALTIMORE2
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
- UNIVERSITY OF UTAH2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | HIV-1 RNA structure effects on latency reversal1R21AI134365-01 | ROUSKIN, SILVIA | WHITEHEAD INSTITUTE FOR BIOMEDICAL RES, MA | $309,688 | ZRG1 |
| 2017 | Role of HIV Rev in Reactivation from Latency1R21AI134208-01 | HAMMARSKJOLD, MARIE-LOUISEREKOSH, DAVID M | UNIVERSITY OF VIRGINIA, VA | $241,500 | ZRG1 |
| 2017 | Targeting of Master Signaling Molecule to Restore Functions of Exhausted HIV-specific CTLs1R21AI129594-01 | LIU, DONGFANG | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $239,250 | ZRG1 |
| 2017 | Imaging-base Automated Screen for Compounds that Induce P-TEFb1R21AI132001-01 | RICE, ANDREW P | BAYLOR COLLEGE OF MEDICINE, TX | $237,750 | ZRG1 |
| 2017 | Discovery and characterization of modified signaling networks in latent HIV-infected T cells using CyTOF1R21AI132013-01A1 | MILLER-JENSEN, KATHRYN | YALE UNIVERSITY, CT | $237,213 | AMCB |
| 2017 | Programming Dendritic Cells to Expose the Persistent HIV-1 Latent Reservoir for Immune Targeting1R21AI131763-01 | MAILLIARD, ROBBIE B | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $233,376 | ZRG1 |
| 2017 | Defining the HLA ligandome of HIV-1 latently infected CD4 + T cells1R21AI134151-01 | ROMERIO, FABIO | UNIVERSITY OF MARYLAND BALTIMORE, MD | $231,750 | ZRG1 |
| 2016 | Dual-Affinity Re-Targeting Proteins for Cure of Newborn Infant HIV-1 Infection1R21AI127022-01 | POLLARA, JUSTIN JOSEPH | DUKE UNIVERSITY, NC | $278,250 | ZRG1 |
| 2016 | PrimeFlow RNA for detection of latently-infected CD4+ T cells1R21AI124776-01 | ROMERIO, FABIO | UNIVERSITY OF MARYLAND BALTIMORE, MD | $262,508 | ZRG1 |
| 2016 | HIV-1-Specific CTL Exhaustion at Immune Synapse1R21AI124769-01 | LIU, DONGFANG | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $250,531 | ZRG1 |
| 2016 | Single-Cell Analysis of HIV Latency Reversal1R21AI127079-01 | LI, JONATHAN | BRIGHAM AND WOMEN'S HOSPITAL, MA | $238,365 | ZRG1 |
| 2016 | Discovery and Characterization of Latency-Reversing Compounds1R21AI124823-01 | BARROWS, LOUIS RPLANELLES, VICENTE | UNIVERSITY OF UTAH, UT | $226,563 | ZRG1 |
| 2016 | CRISPR/Cas9 technology toward understanding HIV latency in primary cells1R21AI123035-01A1 | PLANELLES, VICENTESCHUBERT, HEIDI L | UNIVERSITY OF UTAH, UT | $226,500 | ZRG1 |
| 2016 | The "Kick" Revisited in the "Kick and Kill" Strategy1R21AI119117-01A1 | SLUIS-CREMER, NICOLAS PAUL | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $223,397 | ZRG1 |
| 2016 | Novel Immunomodulating Therapeutics for HIV-1 Treatment1R21AI122808-01 | ALDHAMEN, YASSER | MICHIGAN STATE UNIVERSITY, MI | $223,288 | AIP |
| 2016 | Mechanism of HIV-1 Latency and Reactivation Kinetics Using Single Cell Analysis1R21AI127326-01 | KALPANA, GANJAM V | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC, NY | $208,750 | ZRG1 |
| 2016 | Novel method for evaluating HIV latency and persistence in vivo1R21AI124763-01 | MARSDEN, MATTHEW DAVID | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $192,500 | ZRG1 |
| 2016 | HIV-a Persistence in Myeloid Cell Reservoirs1R21AI127091-01 | STEVENSON, MARIO | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $191,875 | ZRG1 |
| 2015 | Neutralization of the Latent HIV Reservoir in Perinatal Infection1R21HD085859-01 | PERSAUD, DEBORAH | JOHNS HOPKINS UNIVERSITY, MD | $243,000 | ZRG1 |
| 2015 | Viral and Immune Dynamics of Rebound Viremia after VRC01 Administration1R21AI118431-01 | BAR, KATHARINE JUNE | UNIVERSITY OF PENNSYLVANIA, PA | $240,000 | ZRG1 |
| 2015 | The impact of TB co-infection on the reservoir of persistent HIV in vivo1R21AI116295-01A1 | MCCUNE, JOSEPH M | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $239,551 | AOIC |
| 2015 | Bacterial toxin-inspired drug delivery (BTIDD) platforms against latent HIV1R21AI118434-01 | WILSON, BRENDA A. | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $228,968 | ZRG1 |
| 2015 | High-throughput measurement and transcriptome analysis of the latent reservoir using HIV-1 RNA flow-FISH1R21AI118402-01 | HO, YA-CHI | JOHNS HOPKINS UNIVERSITY, MD | $202,500 | ZRG1 |
| 2015 | Characterization of in vivo resting CD4 T cells expressing HIV RNA in ART-treated individuals1R21AI118411-01 | BUZON, MARIA J | FDN INSTITUTE/RESEARCH/VALL D'HEBRON HOS | $162,000 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.